# Study to Compare Lefamulin to Moxifloxacin (With or Without Linezolid) for the Treatment of Adults With Pneumonia

> **NCT02559310** · PHASE3 · COMPLETED · sponsor: **Nabriva Therapeutics AG** · enrollment: 551 (actual)

## Conditions studied

- Community Acquired Pneumonia

## Interventions

- **DRUG:** lefamulin
- **DRUG:** Moxifloxacin
- **DRUG:** Linezolid

## Key facts

- **NCT ID:** NCT02559310
- **Lead sponsor:** Nabriva Therapeutics AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2017-04
- **Final completion:** 2017-05
- **Target enrollment:** 551 (ACTUAL)
- **Last updated:** 2019-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02559310

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02559310, "Study to Compare Lefamulin to Moxifloxacin (With or Without Linezolid) for the Treatment of Adults With Pneumonia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02559310. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*